D.C. cannabis company rolls out new health care brand with a pharma playbook.

Introduction

A Washington, D.C., medical marijuana company is launching a new brand that will sell cannabis products specifically targeting health care providers and researchers.

The new line of products, called Care by Design, follows an approach that combines traditional pharmaceutical techniques with marijuana science to help researchers understand the effects of medical marijuana and its potential risks.

It's particularly useful for doctors who are increasingly asked about marijuana by patients but lack the information needed to respond well.

While some doctors may be reluctant to recommend cannabis for their patients for various reasons, others believe it has the strength to be a viable treatment option for people with cancer or epilepsy, and multiple sclerosis are two examples of neurological disorders.

Care by Design is expected to launch its first product next week, with others following in the coming weeks and months.


A Washington, D.C., medical marijuana company

A Washington, D.C., medical marijuana company is launching a new brand that will sell cannabis products specifically targeting health care providers and researchers.

The new brand, Health for Life Research, aims to provide "high-quality clinical research grade medical cannabis products" to doctors and scientists researching the plant's medicinal properties.

The target audience is not patients or consumers but rather physicians and researchers looking into how cannabis can be used as medicine in daily life.

A study published this week shows that public support for legalizing marijuana has increased significantly over time, especially among younger Americans who are more likely to use it recreationally or medically than older generations.

The new line of products, called Care by Design.

Care by Design is a line of health care products that follows an approach that combines traditional pharmaceutical techniques with marijuana science to help researchers understand the effects of medical marijuana and its potential risks.

According to Dr. Raphael Machoulam, co-founder of Care by Design and professor emeritus at Hebrew University in Israel, the company uses a pharma playbook.

The company has grown a patented process for extracting cannabinoids from cannabidiol (CBD), which he said can be used as an ingredient in foods and beverages and other forms such as capsules or pills.

It also created a new form of CBD oil with greater bioavailability than others currently on the market, meaning that your body can absorb it better than other versions you might take orally.

It's particularly useful for doctors.

The medical establishment has long viewed the cannabis industry as a lawless wasteland of pot-addled hippies and lazy stoners.

But in recent years, many doctors and scientists have seen that marijuana can effectively treat pain, anxiety, depression, and even cancer. Some are even advocating for its outright legalization.

And yet, despite all this progress, major obstacles still stand in the way of the widespread acceptance of cannabis as medicine.

There is a lack of standard research on how best to prescribe it for various conditions, a gap that Dixie is trying to fill with its new brand of THC-infused beverages (which will also contain CBD).

The company's plan is to educate doctors about how these products work and help patients use them safely by offering advice about dosage amounts based on their tolerance levels for THC versus CBD.

This new brand intends to help improve cannabis science

As a D.C.-based cannabis company, this is where we have a lot of expertise. We've worked with doctors, nurses, and other health care providers for years, and we understand how they think about cannabis.

We want to help improve patients' quality of care by bringing in scientific data on dosing, THC/CBD ratios, and other information on best practices for pharmacists and physicians alike.

Conclusion

Ultimately, it's clear that cannabis has a lot of potentials. It's already being used to treat some conditions and could be useful for others in the future.

But research on this drug is still very limited, and there are many unanswered questions about its effects and risks, which keep researchers from recommending it as a medical treatment option for patients.

To address these issues, companies like Care by Design have stepped up their efforts to improve cannabis science by providing products that help researchers better understand how marijuana works in the body while also helping doctors better educate their patients about what they might expect if they choose to try using this drug as an alternative therapy option.

 

Blog by Weed Stop
  • Categories: News